Use this identifier to quote or link this document:

Generic drugs in Spain: price competition vs. moral hazard
Moreno Torres, Ivan
Xarxa de Referència en Economia Aplicada (XREAP)
This paper examines competition between generic and brand-name drugs in the regulated Spanish pharmaceutical market. A nested logit demand model is specified for the three most consumed therapeutic subgroups in Spain: statins (anticholesterol), selective serotonin reuptake inhibitors (antidepressants) and proton pump inhibitors (antiulcers). The model is estimated with instrumental variables from a panel of monthly prescription data from 1999 to 2005. The dataset distinguishes between three different levels of patients’ copayments within the prescriptions and the results show that the greater the level of insurance that the patient has (and therefore the lower the patient’s copayment), the lower the proportion of generic prescriptions made by physicians. It seems that the low level of copayment has delayed the penetration of generics into the Spanish market. Additionally, the estimation of the demand model suggests that the substitution rules and promotional efforts associated with the reference pricing system have increased generic market share, and that being among the first generic entrants has an additional positive effect.
Generic drugs
Medical economics
33 - Economia
334 - Formes d'organització i cooperació en l'economia
338 - Situació econòmica. Política econòmica. Gestió, control i planificació de l'economia. Producció. Serveis. Turisme. Preus
Medicaments genèrics
Economia de la salut
Aquest document està subjecte a una llicència d'ús de Creative Commons, amb la qual es permet copiar, distribuir i comunicar públicament l'obra sempre que se'n citin l'autor original, la universitat i la xarxa i no se'n faci cap ús comercial ni obra derivada, tal com queda estipulat en la llicència d'ús (
59 p.
Working Paper
Xarxa de Referència en Economia Aplicada (XREAP)
XREAP; 2011-04

Full text files in this document

Files Size Format
XREAP2011-04.pdf 495.1 KB PDF

Show full item record